Vivus sues Teva over Qsymia patents; PillPack's adherence tactic;

@FiercePharma: Nexvet regroups as key study on lead dog drug shows 'low probability' of success. FierceAnimalHealth report | Follow @FiercePharma

@EricPFierce: ICYMI from FiercePharmaManufacturing: Sounds like Walgreens would like to buy into another drug distributor like AmerisourceBergen. More | Follow @EricPFierce

@CarlyHFierce: Eisai rejig means sales-force downsizing at a critical moment for Arena's Belviq. FiercePharmaMarketing article | Follow @CarlyHFierce

> Vivus ($VVUS) sued Teva Pharmaceutical ($TEVA) for patent infringement, after the generics maker asked FDA to approve its copy of the weight loss drug Qsymia. Report

Medical Device News

@FierceMedDev: ICYMI from FierceDiagnostics: GE and Veracyte team up for disease diagnostic research collaboration. Article | Follow @FierceMedDev

@VarunSaxena2: Devicemaker AngioDynamics invests in cancer drug delivery aspirant. FierceDrugDelivery story | Follow @VarunSaxena2

@EmilyWFierce: Congress spurs feds to investigate sky-high generic drug prices. More from FiercePharma | Follow @EmilyWFierce

> Citing power morcellator safety scare, insurance lobby calls for tougher regulation of devices. Story

> Startup gets CE mark for diabetic retinopathy screening software, FDA up next. Article

Biotech News

@FierceBiotech: Amgen wins a much-needed FDA OK for heart drug ivabradine. Report | Follow @FierceBiotech

@JohnCFierce: The flimsy case for a miracle ALS drug collapses under expert scrutiny--Remember Genervon? ICYMI yesterday | Follow @JohnCFierce

> Targacept tanks (again) after its last surviving drug program flops. Report

> Actelion launches Phase III MS test for ponesimod. Item

> Jeremy Levin's back, building a rare-disease biotech with failed drugs. Article

CRO News

> Catalent wraps up a $52M manufacturing expansion. Item

> Quintiles deepens its Latin American ties with Argentine partnership. Article

> Two ophthalmology CROs join forces for ocular R&D. Report

> Aptuit pairs up with an Italian CRO for drug discovery. News

> Clinipace bags CRO Accovion in its latest global buyout. Story

Vaccines News

> Merck takes its Ebola vaccine to Phase III in Sierra Leone. Report

> Healthcare systems could benefit from covering HPV vaccine in boys, study says. Item

> Janssen looks to Ichor's electroporation delivery system for hep B jab. Story

> Aduro swings for the fences with $119M IPO. Article

> AstraZeneca's MedImmune gets RSV candidate fast-tracked. News

Pharma Manufacturing News

> Norwich Pharma spending $26M on new equipment. Item

> Sanofi Pasteur U.S. operation part of dengue vaccine buildup. More

> FDA stepping up efforts to replenish U.S. saline solution supplies. Article

> Bayer to pump $100M into U.S. facility focused on hemophilia drugs. Story

> GSK plant in Ireland making headway on reducing carbon footprint. Report

Pharma Asia News

> Quick China dealmaking as TVM, Lummy tie with Argos on oncology candidate. Article

> China's big pharma companies get thumbs-up from Moody's on reform push. News

> Australia to cut government benefits if parents don't vaccinate children. Report

> PerkinElmer gets China marketing authorization on Genetic Screening system. More

> Alibaba's latest move in China online drug sales is $2.51B shift of Tmall. Story

And Finally... Pharmacy start-up, PillPack, is packaging patients' entire medication regimens by the time of day pills are to be taken, rather than individually, hoping to improve adherence. Report

Suggested Articles

After a slow start, Teva's Ajovy launch is improving following the FDA approval for an autoinjector.

After Trump's "Buy American" executive order for essential medicines, the pharma industry is pushing back.

The U.S. is slamming the brakes on its $765 million loan to Kodak amid insider trading allegations and questions about its fitness for the job.